Skip to main content

Alnylam stock more than tripled last year — and the company says 2018 will be big

The company has a number of product launches, clinical trials and expansion plans in the works.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.